READ-ONLY DIGITIZATION RESULT
Sustained resolution of enthesitis and peripheral arthritis over 104 weeks with bimekizumab in axial spondyloarthritis.
RMD Open · 2025-Oct-22 · PMID 41125403
Panel Mean_MASES_SEM_提取完成待 EXE 对齐验证
MASES (Enthesitis)
Graphical summary of study results. a BKZ-randomised patients; b BKZ-randomised and placebo-switched patients; c placebo-randomised patients. axSpA, axial spondyloarthritis; BKZ, bimekizumab; DAPSA, Disease Activity Index in Psoriatic Arthritis; LDA, low disease activity; MASES: Maastricht Ankylosing Spondylitis Enthesitis Score; MI: multiple imputation; nr-axSpA: non-radiographic axSpA; NRI: non-responder imputation; OC: observed case; PBO: placebo; r-axSpA: radiographic axSpA; REM: remission; SJC: swollen joint count.
算法:legacy-0.5.0引擎:enhanced-linux
曲线数据
网页最多预览 200 行,完整数据请下载 CSV 或 JSON。
当前面板没有可预览的 `curves_mapped.csv` 数据。
历史版本(1)
重跑只新增版本,不覆盖旧结果;正式可用状态仅授予通过 EXE 基准或人工复核的版本。
| 版本 | 状态 | 验证 | 曲线 | 时间 |
|---|---|---|---|---|
| legacy-0.5.0 | complete | 待验证 | 2 | 2026-07-23T18:00:14+00:00 |